| CAS ID: | 60-23-1 |
| Molecular Formula: | C2H7NS |
| Molecular Weight: | 77.2 g/mol |
| Monoisotopic Mass: | 77.0299 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | CYSTAGON | MERCAPTAMINE | CI-9148 | MEA | CYSTARAN | CYSTEAMINE HYDROCHLORIDE | L-1573 | PROCYSBI | Cystagon | CYSTEAMINE BITARTRATE | CYSTEAMINE |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT03000348 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | December 22, 2016 | Last Verified | June 26, 2018 |
| Sponsor | NovaBiotics Ltd. | ||
Trial Record 2
| ClinicalTrial ID | NCT02212431 | Disease | Cystic fibrosis |
| Phase | Phase 1,Phase 2 | Status | Completed |
| First Received | August 8, 2014 | Last Verified | November 5, 2015 |
| Sponsor | University of Aberdeen | ||